SEC Form 4 · accession 0001209191-16-092454
Armata Pharmaceuticals, Inc. · ARMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Robert Martin
Officer — Chief Financial Officer
Period of report
Jan 18, 2016
Accepted (ET)
Jan 20, 2016 · 2:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921114
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.85 | Jan 18, 2016 | A | 99,919 | A | — | Jan 17, 2026 | Common Stock | 99,919 | 99,919 | D |
Explanation of responses
- F11/4th of the shares subject to the option vest on January 18, 2017. The remainder of the shares vest in equal monthly installments thereafter over the next three years.